Gönülal, M. Et Al. 2022. Ixekizumab for the treatment of the patients with moderate to severe plaque psoriasis: Clinical data from a real-world experience. Dermatologic Therapy , vol.35, no.12 .

Gönülal, M., Altunay, İ. K., Doğan, S., Türkmen, M., Balcı, D. D., & ÖZTÜRKCAN, S., (2022). Ixekizumab for the treatment of the patients with moderate to severe plaque psoriasis: Clinical data from a real-world experience. Dermatologic Therapy , vol.35, no.12.

Gönülal, Melis Et Al. "Ixekizumab for the treatment of the patients with moderate to severe plaque psoriasis: Clinical data from a real-world experience," Dermatologic Therapy , vol.35, no.12, 2022

Gönülal, Melis Et Al. "Ixekizumab for the treatment of the patients with moderate to severe plaque psoriasis: Clinical data from a real-world experience." Dermatologic Therapy , vol.35, no.12, 2022

Gönülal, M. Et Al. (2022) . "Ixekizumab for the treatment of the patients with moderate to severe plaque psoriasis: Clinical data from a real-world experience." Dermatologic Therapy , vol.35, no.12.

@article{article, author={Melis Gönülal Et Al. }, title={Ixekizumab for the treatment of the patients with moderate to severe plaque psoriasis: Clinical data from a real-world experience}, journal={Dermatologic Therapy}, year=2022}